| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0009 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |